DXM + Pethidine (meperidine)

https://dxm-atlas.org/en/interactions/pethidine/

Compare

Key points for this combination

In cell tests with human transporters, pethidine (meperidine) inhibited serotonin reuptake [5]. The oral meperidine label describes respiratory depression and seizures associated with metabolite accumulation during prolonged use [52].

General concepts in this text

Reuptake

Return of a released neurotransmitter into a cell through a transporter protein.

Allows neurotransmitter recycling.

Sources: Reuptake

Metabolite

A substance formed when another substance is chemically transformed in the body.

Some transformation products retain pharmacological activity.

Sources: Metabolite

Serotonin

A neurotransmitter: a substance that carries a chemical signal from a nerve cell.

There are different serotonin receptors in the brain and other parts of the body. The response to the signal depends on the receptor and its location.

Sources: Serotonin

Drug metabolism

Chemical transformation of a medicine in the body.

The resulting substances are metabolites. Transformation can reduce or increase pharmacological activity.

Sources: Drug metabolism

How well is this understood?

Mechanism confidence: high

Confidence in the mechanism: high

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Confidence in human DXM data: low

Confidence in direct human evidence involving DXM: low

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method

How to read ratings and study limits

How do the substances interact?

How can the effects add up?

Mechanism: OP — μ-opioid effects
ⓘ

μ-opioid effects and associated respiratory hazards

Mechanism: SERT — Serotonin reuptake
ⓘ

SERT

A transporter protein involved in serotonin reuptake.

Inhibiting transport differs from acting on receptors.

Sources: SERT

What hazards does the other substance have?

Product prescribing information; warnings about the opioid’s own effects.

  1. The oral meperidine label warns of respiratory depression.
  2. The oral meperidine label associates prolonged use and metabolite accumulation with toxicity including seizures.

What remains unknown?

The scope is the opioid’s own pharmacology as described in its prescribing information.

Sources

Check the review’s wording

SERT inhibition [5]; respiratory depression and seizure potential of its metabolite, with accumulation during prolonged use [52]

Combination row in the review: OP — μ-opioid effects; SERT — Serotonin reuptake; SEIZ — An additional seizure-related concern

Evidence and sources

Prescribing information

[52] · DEMEROL oral prescribing information

Respiratory depression

What does the label say?

The oral meperidine label warns of respiratory depression.

Source type

Product prescribing information; warnings about the opioid’s own effects.

Metabolite accumulation and seizures

What does the label say?

The oral meperidine label associates prolonged use and metabolite accumulation with toxicity including seizures.

What does this label information cover?

The scope is the opioid’s own pharmacology as described in its prescribing information.

Scientific review: 6. Opioids and other depressants

Related entries

Reference

Open the source and related combinations →